New hopes diagnose men with prostate cancer recurrence years earlier
Tuesday, October 20th, 2009 Posted in prostate cancer diagnosis | No Comments »Using an extremely sensitive tool based on nanotechnology, a research team of Northwestern University, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy. The study conclusions will be published online during the week of ...
Application of active surveillance protocols for low risk localized prostate
Monday, October 19th, 2009 Posted in watchful waiting | No Comments »A recent study focused the problems with application of active surveillance protocols for low risk localized prostate cancer. Researchers point out the difficulty in choosing the appropriate patients to counsel regarding active surveillance. Clearly the current diagnostic tests are not adequate. The ...
Natural history of persistently elevated prostate specific antigen after radical prostatectomy
Sunday, October 18th, 2009 Posted in prostatectomy | No Comments »A recent study at Department of Surgery and Duke Prostate Center, Durham, North Carolina. has examined natural history, predictors of biochemical recurrence and all cause mortality in patients with persistently elevated prostate specific antigen after radical prostatectomy in the Shared ...
Concerns related to robotic prostate cancer surgery
Friday, October 16th, 2009 Posted in Uncategorized | No Comments »A recent national study, which appeared in Wednesday's Journal of the American Medical Association, is raising some concerns about robotic prostate cancer surgery, a procedure widely used by local hospitals and promoted as having fewer complications than traditional prostate surgery. The ...
Srudy: Cystoprostatectomy as a treatment of prostate cancer
Thursday, October 15th, 2009 Posted in prostatectomy | No Comments »A recent study at Akita University School of Medicine, Akita, Japan, suggests that cystoprostatectomy followed by immediate hormone therapy may be a feasible treatment option to achieve excellent local control for patients with previously untreated PCa, even in the presence ...
The downstaging of prostate cancer is due to the increased expertise of surgeons
Wednesday, October 14th, 2009 Posted in prostate cancer, prostatectomy | No Comments »A recent study at The Mount Sinai Medical Center in New York City, which surveyed almost 13,000 American men who had a radical prostatectomy (surgical removal of a cancerous prostate gland) between 1987 and 2005, found that only 12% of ...
Advantages and also certain complications related to minimally invasive radical prostatectomy
Tuesday, October 13th, 2009 Posted in prostatectomy | No Comments »New research at Brigham and Women's Hospital, Boston indicates that the use of minimally invasive procedures (including the use of robotic assistance) for radical prostatectomy (MIRP), which have increased significantly in recent years, may shorten hospital stays and decrease respiratory ...
Genistein has been associated with decreased metastasis and mortality in prostate cancer patients
Monday, October 12th, 2009 Posted in alternative treatments, prostate cancer | No Comments »A recent research from the United States, suggests that dietary intake of genistein by patients with prostate cancer has been associated with decreased metastasis and mortality. The researchers concluded for the first time, that genistein treatment, compared with no treatment, was ...
Criotherapy in Scotland with “encouraging” results
Sunday, October 11th, 2009 Posted in prostate cryotherapy | No Comments »Doctors in Scotland have revealed they are giving tumours frostbite to fight prostate cancer. Since the procedure, known as cryotherapy, was introduced last October, 13 men have undergone the treatment, with "encouraging" results. During this minimally invasive procedure, the tumours are ...
Killer prostate cancer test hope
Saturday, October 10th, 2009 Posted in prostate cancer diagnosis | No Comments »Scientists from University of Liverpool have discovered a protein that predicts survival from prostate cancer at diagnosis. The research team found the presence of heat shock protein-27 (Hsp-27) was a key marker of how prostate cancer would progress. According to ...